This editorial highlights remarkable advancements in tailored medical treatment strategies for pancreatic neuroendocrine tumors. Cytoreductive surgery and somatostatin analogs are key in managing tumors, with additional treatment options available for refractory patients. Different subtypes require distinct therapeutic approaches, and ongoing research on the genetic basis and immunotherapies offers promising avenues for future patient outcomes.
Editorial by Giri S and Sahoo J in World J Gastroenterol
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.